Form 4 for NREF NexPoint Real Estate Finance, Inc.

Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001437749-22-021926 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-09-06	2022-09-01	NREF	DONDERO JAMES D	Pres, Dir, 10%	P - Purchase	$23.78	+2,887	13.2K	+28%	+$68.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	8.50% Series A Cumulative Redeemable Preferred Stock	2022-09-01	P	A	1,250	$23.75	14,461	I See Footnote	—	—	(F1) These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
2	Common	8.50% Series A Cumulative Redeemable Preferred Stock	2022-09-01	P	A	1,637	$23.80	13,211	I See Footnote	—	—	(F1) These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.